Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent

Nature Medicine

Volumn 12, Issue 3, 2006, Pages 330-334

  Machado, Fabiana S ^a   Johndrow, James E ^b,c   Esper, Lisia ^a   Dias, Alexandra ^a   Bafica, Andre ^b,d   Serhan, Charles N ^e   Aliberti, Julio ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AROMATIC HYDROCARBON RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIPOXIN A; LIPOXIN RECEPTOR; SUPPRESSOR OF CYTOKINE SIGNALING 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATION; INHIBITION KINETICS; INTRACELLULAR SPACE; LEUKOCYTE; MICROBIAL ACTIVITY; MICROBIAL GROWTH; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; TOXOPLASMA GONDII;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BRAIN; CELLS, CULTURED; DENDRITIC CELLS; INFLAMMATION; INTERLEUKIN-12; LIPOXINS; MICE; MICE, INBRED C57BL; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; SPLEEN; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TOXOPLASMA;

ANIMALIA; TOXOPLASMA GONDII;

EID: 33644831336     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1355     Document Type: Article

References (23)

1. Aliberti, J. et al. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 3, 76-82 (2002).
2. Aliberti, J., Serhan, C. & Sher, A. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 196, 1253-1262 (2002).
3. Bafica, A. et al. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J. Clin. Invest. 115, 1601-1606 (2005).
4. Goh, J., Godson, C., Brady, H.R. & Macmathuna, P. Lipoxins: pro-resolution lipid mediators in intestinal inflammation. Gastroenterology 124, 1043-1054 (2003).
5. Karp, C.L. et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat. Immunol. 5, 388-392 (2004).
6. Kieran, N.E., Maderna, P. & Godson, C. Lipoxins: potential anti-inflammatory, pro-resolution, and antifibrotic mediators in renal disease. Kidney Int. 65, 1145-1154 (2004).
7. Samuelsson, B. Arachidonic acid metabolism: role in inflammation. Z. Rheumatol. 50 Suppl 1, 3-6 (1991).
8. Van Dyke, T.E. & Serhan, C.N. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J. Dent. Res. 82, 82-90 (2003).
9. Bandeira-Melo, C. et al. Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J. Immunol. 164, 2267-2271 (2000).
10. Clish, C.B. et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. USA 96, 8247-8252 (1999).
11. Hachicha, M., Pouliot, M., Petasis, N.A. & Serhan, C.N. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1α-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J. Exp. Med. 189, 1923-1930 (1999).
12. Ohira, T. et al. A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils. J. Immunol. 173, 2091-2098 (2004).
13. Ramstedt, U., Ng, J., Wigzell, H., Serhan, C.N. & Samuelsson, B. Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity: effects on intracellular cAMP and target cell binding. J. Immunol. 135, 3434-3438 (1985).
14. Maddox, J.F. et al. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J. Biol. Chem. 272, 6972-6978 (1997).
15. Devchand, P.R. et al. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J. 17, 652-659 (2003).
16. Schaldach, C.M., Riby, J. & Bjeldanes, L.F. Lipoxin A4: a new class of ligand for the Ah receptor. Biochemistry 38, 7594-7600 (1999).
17. Alexander, W.S. & Hilton, D.J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22, 503-529 (2004).
18. Leonard, M.O. et al. 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. J. Am. Soc. Nephrol. 13, 1657-1662 (2002).
19. Reis e Sousa, C. et al. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 11, 637-647 (1999).
20. Davey, H.W., McLachlan, M.J., Wilkins, R.J., Hilton, D.J. & Adams, T.E. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver. Mol. Cell. Endocrinol. 158, 111-116 (1999).
21. Dahlgren, C. et al. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val- DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood 95, 1810-1818 (2000).
22. Kile, B.T. et al. The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci. 27, 235-241 (2002).
23. Qiu, F.H., Devchand, P.R., Wada, K. & Serhan, C.N. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils. FASEB J. 15, 2736-2738 (2001).